| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.6M | +35.8% |
| R&D Expense | $116.7M | +30.6% |
| SG&A Expense | $32.8M | +14.1% |
| Operating Income | -$147.1M | -26.1% |
| Pre-tax Income | -$146.5M | -28.6% |
| Income Tax | $491K | +792.7% |
| Net Income | -$146.9M | -29.0% |
| EPS (Basic) | -$1.05 | +10.3% |
| EPS (Diluted) | -$1.05 | +10.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $194.2M | +498.2% |
| Current Assets | $212.9M | +379.7% |
| Total Assets | $233.7M | +256.0% |
| Current Liabilities | $58.0M | +86.4% |
| Total Liabilities | $64.9M | +69.7% |
| Stockholders' Equity | $168.8M | +516.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$121.2M | -16.0% |
| Capital Expenditures | $532K | -77.2% |
| Investing Cash Flow | -$1.4M | -80.8% |
| Financing Cash Flow | $276.2M | — |
| Free Cash Flow | -$121.7M | -14.0% |